{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:50:11Z","timestamp":1790117411484,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Patients with obstructive sleep apnea (OSA) might be at risk of gout because of pathophysiological mechanisms that can lead to hyperuricemia and eventually gout or because of shared risk factors between both diseases. The objective of the present study was to investigate the risk of gout in patients with OSA.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A population-based case-control study using the UK Clinical Practice Research Datalink GOLD including all patients aged 40\u2009years and older with a first diagnosis of gout between 1987 and 2014. Gout cases were matched by year of birth, sex, and practice to non-gout controls. Conditional logistic regression estimated the risk of gout with an earlier diagnosis of OSA. Analyses were adjusted for lifestyle factors, comorbidities, and recent drug use.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>One hundred eleven thousand five hundred nine cases were matched with 210,241 controls. Patients with OSA were at increased risk of gout (OR 1.86; 95%CI (1.71\u20132.02). However, this association disappeared (OR 1.05; 95% CI 0.96\u20131.16) after adjustment for smoking status, body mass index (BMI), alcohol use, a history of heart failure, diabetes mellitus, renal function, and recent use of diuretics and other medications. Among females with OSA and patients with OSA associated with heart failure, renal impairment, or higher BMI, the risk of gout was however still increased when compared to the total control population.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This study showed that the observed association between OSA and gout disappeared after adjustment.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13075-020-02176-1","type":"journal-article","created":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T17:02:44Z","timestamp":1587834164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Obstructive sleep apnea and the risk of gout: a population-based case-control study"],"prefix":"10.1186","volume":"22","author":[{"given":"Caroline","family":"van Durme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Spaetgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Nielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Sastry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Boonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,25]]},"reference":[{"key":"2176_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/1471-2474-13-180","volume":"13","author":"L Harrold","year":"2012","unstructured":"Harrold L, Mazor K, Peterson D, Naz N, Firneno C, Yood R. Patients\u2019 knowledge and beliefs concerning gout and its treatment: a population based study. BMC Musculoskelet Disord. 2012;13:180.","journal-title":"BMC Musculoskelet Disord"},{"key":"2176_CR2","unstructured":"Singh JA, Strand V. Gout is associated with more comorbidities, poorer health related quality of life and higher health care utilization in US veterans. Ann Rheum Dis. 2008;67(9):1310\u20136."},{"issue":"1","key":"2176_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/rheumatology\/kes253","volume":"52","author":"P Robinson","year":"2013","unstructured":"Robinson P, Merriman T, Herbison P, Highton J. Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999-2009. Rheumatology. 2013;52(1):118\u201326.","journal-title":"Rheumatology"},{"issue":"12","key":"2176_CR4","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1002\/art.39330","volume":"67","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Peloquin CE, Dubreuil M, Roddy E, Lu N, Neogi T, et al. Sleep apnea and the risk of incident gout: a population-based, body mass index-matched cohort study. Arthritis Rheumatol (Hoboken, NJ). 2015;67(12):3298\u2013302.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"5","key":"2176_CR5","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1378\/chest.122.5.1686","volume":"122","author":"H Saito","year":"2002","unstructured":"Saito H, Nishimura M, Shibuya E, Makita H, Tsujino I, Miyamoto K, et al. Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine. Chest. 2002;122(5):1686\u201394.","journal-title":"Chest"},{"issue":"2","key":"2176_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.mehy.2011.10.029","volume":"78","author":"B Abrams","year":"2012","unstructured":"Abrams B. High prevalence of gout with sleep apnea. Med Hypotheses. 2012;78(2):349.","journal-title":"Med Hypotheses"},{"issue":"5","key":"2176_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ejim.2014.04.005","volume":"25","author":"A Kanbay","year":"2014","unstructured":"Kanbay A, Inonu H, Solak Y, Erden A, Uslu E, Yuksel SA, et al. Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome. Eur J Intern Med. 2014;25(5):471\u20136.","journal-title":"Eur J Intern Med"},{"issue":"4","key":"2176_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1183\/09031936.00180108","volume":"33","author":"P Jennum","year":"2009","unstructured":"Jennum P, Riha RL. Epidemiology of sleep apnoea\/hypopnoea syndrome and sleep-disordered breathing. Eur Respir J. 2009;33(4):907\u201314.","journal-title":"Eur Respir J"},{"issue":"1","key":"2176_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/art.40662","volume":"71","author":"M Blagojevic-Bucknall","year":"2019","unstructured":"Blagojevic-Bucknall M, Mallen C, Muller S, Hayward R, West S, Choi H, et al. The risk of gout among patients with sleep apnea: a matched cohort study. Arthritis Rheumatol (Hoboken, NJ). 2019;71(1):154\u201360.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"2176_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3899\/jrheum.140457","volume":"92","author":"C van Durme","year":"2014","unstructured":"van Durme C, van Echteld IA, Falzon L, Aletaha D, van der Heijde DM, Landewe RB. Cardiovascular risk factors and comorbidities in patients with hyperuricemia and\/or gout: a systematic review of the literature. J Rheumatol Suppl. 2014;92:9\u201314.","journal-title":"J Rheumatol Suppl"},{"issue":"2","key":"2176_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5665\/sleep.4400","volume":"38","author":"YC Lee","year":"2015","unstructured":"Lee YC, Hung SY, Wang HK, Lin CW, Wang HH, Chen SW, et al. Sleep apnea and the risk of chronic kidney disease: a nationwide population-based cohort study. Sleep. 2015;38(2):213\u201321.","journal-title":"Sleep"},{"issue":"1","key":"2176_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000282","volume":"2","author":"E Krishnan","year":"2012","unstructured":"Krishnan E. Gout and the risk for incident heart failure and systolic dysfunction. BMJ Open. 2012;2(1):e000282.","journal-title":"BMJ Open"},{"issue":"5","key":"2176_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.cardfail.2011.01.013","volume":"17","author":"TE Herrscher","year":"2011","unstructured":"Herrscher TE, Akre H, Overland B, Sandvik L, Westheim AS. High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J Card Fail. 2011;17(5):420\u20135.","journal-title":"J Card Fail"},{"issue":"3","key":"2176_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827\u201336.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2176_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","volume":"69","author":"E Herrett","year":"2010","unstructured":"Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010;69(1):4\u201314.","journal-title":"Br J Clin Pharmacol"},{"issue":"32","key":"2176_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001358","volume":"94","author":"JM Wijnands","year":"2015","unstructured":"Wijnands JM, van Durme CM, Driessen JH, Boonen A, Klop C, Leufkens B, et al. Individuals with type 2 diabetes mellitus are at an increased risk of gout but this is not due to diabetes: a population-based cohort study. Medicine. 2015;94(32):e1358.","journal-title":"Medicine"},{"issue":"2","key":"2176_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1046\/j.1365-2125.1997.00647.x","volume":"44","author":"CR Meier","year":"1997","unstructured":"Meier CR, Jick H. Omeprazole, other antiulcer drugs and newly diagnosed gout. Br J Clin Pharmacol. 1997;44(2):175\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2176_CR18","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/s41598-017-01588-5","volume":"7","author":"B Spaetgens","year":"2017","unstructured":"Spaetgens B, de Vries F, Driessen JHM, Leufkens HG, Souverein PC, Boonen A, et al. Risk of infections in patients with gout: a population-based cohort study. Sci Rep. 2017;7(1):1429.","journal-title":"Sci Rep"},{"issue":"9","key":"2176_CR19","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/pds.3844","volume":"24","author":"DM Carbonari","year":"2015","unstructured":"Carbonari DM, Saine ME, Newcomb CW, Blak B, Roy JA, Haynes K, et al. Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN). Pharmacoepidemiol Drug Saf. 2015;24(9):999\u20131003.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"2176_CR20","doi-asserted-by":"publisher","first-page":"e27233","DOI":"10.5812\/numonthly.7(3)2015.27233","volume":"7","author":"OS Prasad Sah","year":"2015","unstructured":"Prasad Sah OS, Qing YX. Associations between hyperuricemia and chronic kidney disease: a review. Nephrourol Mon. 2015;7(3):e27233\u2013e.","journal-title":"Nephrourol Mon"},{"issue":"8","key":"2176_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104519","volume":"9","author":"N McCormick","year":"2014","unstructured":"McCormick N, Lacaille D, Bhole V, Avina-Zubieta JA. Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis. PLoS One. 2014;9(8):e104519.","journal-title":"PLoS One"},{"issue":"9","key":"2176_CR22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/ejhf.709","volume":"19","author":"S Koudstaal","year":"2017","unstructured":"Koudstaal S, Pujades-Rodriguez M, Denaxas S, Gho J, Shah AD, Yu N, et al. Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people. Eur J Heart Fail. 2017;19(9):1119\u201327.","journal-title":"Eur J Heart Fail"},{"key":"2176_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/1471-2369-14-164","volume":"14","author":"D Gustafsson","year":"2013","unstructured":"Gustafsson D, Unwin R. The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol. 2013;14:164.","journal-title":"BMC Nephrol"},{"issue":"6","key":"2176_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/eurheartj\/ehq473","volume":"32","author":"GS Filippatos","year":"2011","unstructured":"Filippatos GS, Ahmed MI, Gladden JD, Mujib M, Aban IB, Love TE, et al. Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data. Eur Heart J. 2011;32(6):712\u201320.","journal-title":"Eur Heart J"},{"key":"2176_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijcard.2016.11.077","volume":"228","author":"Y Otaki","year":"2017","unstructured":"Otaki Y, Watanabe T, Kinoshita D, Yokoyama M, Takahashi T, Toshima T, et al. Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure. Int J Cardiol. 2017;228:151\u20137.","journal-title":"Int J Cardiol"},{"issue":"20","key":"2176_CR26","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1161\/hc4501.098928","volume":"104","author":"TP Cappola","year":"2001","unstructured":"Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation. 2001;104(20):2407\u201311.","journal-title":"Circulation"},{"issue":"6","key":"2176_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jcrc.2012.03.011","volume":"27","author":"F Malek","year":"2012","unstructured":"Malek F, Ostadal P, Parenica J, Jarkovsky J, Vitovec J, Widimsky P, et al. Uric acid, allopurinol therapy, and mortality in patients with acute heart failure--results of the Acute HEart FAilure Database registry. J Crit Care. 2012;27(6):737 e11\u201324.","journal-title":"J Crit Care"},{"issue":"1","key":"2176_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","volume":"3","author":"K Ogino","year":"2010","unstructured":"Ogino K, Kato M, Furuse Y, Kinugasa Y, Ishida K, Osaki S, et al. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail. 2010;3(1):73\u201381.","journal-title":"Circ Heart Fail"},{"issue":"7","key":"2176_CR29","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.cjca.2015.04.017","volume":"31","author":"OD Lyons","year":"2015","unstructured":"Lyons OD, Bradley TD. Heart failure and sleep apnea. Can J Cardiol. 2015;31(7):898\u2013908.","journal-title":"Can J Cardiol"},{"issue":"12","key":"2176_CR30","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1093\/rheumatology\/ken391","volume":"47","author":"K Pui","year":"2008","unstructured":"Pui K, Waddell C, Dalbeth N. Early onset of hyperuricaemia and gout following treatment for female to male gender reassignment. Rheumatology (Oxford, England). 2008;47(12):1840\u20131.","journal-title":"Rheumatology (Oxford, England)"},{"key":"2176_CR31","doi-asserted-by":"publisher","first-page":"1764837","DOI":"10.1155\/2016\/1764837","volume":"2016","author":"A Wimms","year":"2016","unstructured":"Wimms A, Woehrle H, Ketheeswaran S, Ramanan D, Armitstead J. Obstructive sleep apnea in women: specific issues and interventions. Biomed Res Int. 2016;2016:1764837.","journal-title":"Biomed Res Int"},{"key":"2176_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1476-511X-13-113","volume":"13","author":"XC Wang","year":"2014","unstructured":"Wang XC, Liu H, Huang YY, Sun H, Bu L, Qu S. Head fat is a novel method of measuring metabolic disorder in Chinese obese patients. Lipids Health Dis. 2014;13:113.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"2176_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1155\/2006\/834786","volume":"13","author":"K Parameswaran","year":"2006","unstructured":"Parameswaran K, Todd DC, Soth M. Altered respiratory physiology in obesity. Can Respir J. 2006;13(4):203\u201310.","journal-title":"Can Respir J"},{"issue":"8","key":"2176_CR34","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.200905-0773OC","volume":"180","author":"PE Peppard","year":"2009","unstructured":"Peppard PE, Ward NR, Morrell MJ. The impact of obesity on oxygen desaturation during sleep-disordered breathing. Am J Respir Crit Care Med. 2009;180(8):788\u201393.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2176_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1055\/s-2002-32318","volume":"6","author":"V Kapur","year":"2002","unstructured":"Kapur V, Strohl KP, Redline S, Iber C, O'Connor G, Nieto J. Underdiagnosis of sleep apnea syndrome in U.S. communities. Sleep Breath. 2002;6(2):49\u201354.","journal-title":"Sleep Breath"},{"issue":"3","key":"2176_CR36","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/ije\/dyi060","volume":"34","author":"AM Jurek","year":"2005","unstructured":"Jurek AM, Greenland S, Maldonado G, Church TR. Proper interpretation of non-differential misclassification effects: expectations vs observations. Int J Epidemiol. 2005;34(3):680\u20137.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"2176_CR37","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/EDE.0b013e3181a819a1","volume":"20","author":"EF Schisterman","year":"2009","unstructured":"Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology (Cambridge, Mass). 2009;20(4):488\u201395.","journal-title":"Epidemiology (Cambridge, Mass)"},{"issue":"4","key":"2176_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019029","volume":"6","author":"SB Ahmed","year":"2011","unstructured":"Ahmed SB, Ronksley PE, Hemmelgarn BR, Tsai WH, Manns BJ, Tonelli M, et al. Nocturnal hypoxia and loss of kidney function. PLoS One. 2011;6(4):e19029.","journal-title":"PLoS One"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02176-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T23:51:20Z","timestamp":1619308280000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02176-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,25]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2176"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02176-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,25]]},"assertion":[{"value":"7 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CPRD has been granted Multiple Research Ethics Committee approval (05\/MRE04\/87) to undertake purely observational studies with external data linkages, including ONS mortality data. The present study is based on anonymized and unidentifiable CPRD data and is also approved by the Independent Scientific Advisory Committee (ISAC) of the Medicine and Healthcare products Regulatory Agency (protocol number 14_231R), which is primarily responsible for reviewing the study protocols. In the case of this observational research, no further ethical approval was deemed necessary by ISAC.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any individual data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FV currently supervises two PhD students who are employed with F. Hoffmann La Roche Ltd. (Basel, Switzerland and Welwyn Garden City, UK). He has not received any feeds or reimbursements for this. The topics of their PhD theses do not relate to the current manuscript.MS received speakers\u2019 fees for a lecture on obstructive sleep apnea from the European Academy of Dental Sleep Medicine (2015) as well as for a lecture on COPD and Sleep from Astra Zeneca (2016).CvD received speakers\u2019 fees for lectures on gout and advisory board (Gr\u00fcnenthal) and speaker fees for a lecture on biosimilars (Amgen). The topic of the lecture and the advisory board on gout was not related to the topic of the present article.BS: none to declareJN: none to declareJD: none to declare","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}